BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 24574518)

  • 21. Autotaxin Regulates Maintenance of Ovarian Cancer Stem Cells through Lysophosphatidic Acid-Mediated Autocrine Mechanism.
    Seo EJ; Kwon YW; Jang IH; Kim DK; Lee SI; Choi EJ; Kim KH; Suh DS; Lee JH; Choi KU; Lee JW; Mok HJ; Kim KP; Matsumoto H; Aoki J; Kim JH
    Stem Cells; 2016 Mar; 34(3):551-64. PubMed ID: 26800320
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Autocrine interleukin-23 promotes self-renewal of CD133+ ovarian cancer stem-like cells.
    Wang D; Xiang T; Zhao Z; Lin K; Yin P; Jiang L; Liang Z; Zhu B
    Oncotarget; 2016 Nov; 7(46):76006-76020. PubMed ID: 27738346
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Requirement of JNK signaling for self-renewal and tumor-initiating capacity of ovarian cancer stem cells.
    Seino M; Okada M; Shibuya K; Seino S; Suzuki S; Ohta T; Kurachi H; Kitanaka C
    Anticancer Res; 2014 Sep; 34(9):4723-31. PubMed ID: 25202050
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ovarian cancer stem cells are enriched in side population and aldehyde dehydrogenase bright overlapping population.
    Yasuda K; Torigoe T; Morita R; Kuroda T; Takahashi A; Matsuzaki J; Kochin V; Asanuma H; Hasegawa T; Saito T; Hirohashi Y; Sato N
    PLoS One; 2013; 8(8):e68187. PubMed ID: 23967051
    [TBL] [Abstract][Full Text] [Related]  

  • 25. ALDH1A1+ ovarian cancer stem cells co-expressing surface markers CD24, EPHA1 and CD9 form tumours in vivo.
    Nagare RP; Sneha S; Krishnapriya S; Ramachandran B; Murhekar K; Vasudevan S; Shabna A; Ganesan TS
    Exp Cell Res; 2020 Jul; 392(1):112009. PubMed ID: 32305326
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Galectin-3 augments tumor initiating property and tumorigenicity of lung cancer through interaction with β-catenin.
    Chung LY; Tang SJ; Wu YC; Sun GH; Liu HY; Sun KH
    Oncotarget; 2015 Mar; 6(7):4936-52. PubMed ID: 25669973
    [TBL] [Abstract][Full Text] [Related]  

  • 27. CD133 expression defines a tumor initiating cell population in primary human ovarian cancer.
    Curley MD; Therrien VA; Cummings CL; Sergent PA; Koulouris CR; Friel AM; Roberts DJ; Seiden MV; Scadden DT; Rueda BR; Foster R
    Stem Cells; 2009 Dec; 27(12):2875-83. PubMed ID: 19816957
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Expression of CD44
    Sihombing UHM; Andrijono ; Purwoto G; Gandamihardja S; Harahap AR; Rustamadji P; Kekalih A; Widyawati R; Fuady DR
    Gynecol Oncol Rep; 2022 Aug; 42():101005. PubMed ID: 35707599
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Co-expressed functional module-related genes in ovarian cancer stem cells represent novel prognostic biomarkers in ovarian cancer.
    Gov E
    Syst Biol Reprod Med; 2020 Aug; 66(4):255-266. PubMed ID: 32441533
    [TBL] [Abstract][Full Text] [Related]  

  • 30. ALDH1-high ovarian cancer stem-like cells can be isolated from serous and clear cell adenocarcinoma cells, and ALDH1 high expression is associated with poor prognosis.
    Kuroda T; Hirohashi Y; Torigoe T; Yasuda K; Takahashi A; Asanuma H; Morita R; Mariya T; Asano T; Mizuuchi M; Saito T; Sato N
    PLoS One; 2013; 8(6):e65158. PubMed ID: 23762304
    [TBL] [Abstract][Full Text] [Related]  

  • 31. LIM-homeobox transcription factor 1, alpha (LMX1A) inhibits tumourigenesis, epithelial-mesenchymal transition and stem-like properties of epithelial ovarian cancer.
    Chao TK; Yo YT; Liao YP; Wang YC; Su PH; Huang TS; Lai HC
    Gynecol Oncol; 2013 Mar; 128(3):475-82. PubMed ID: 23270808
    [TBL] [Abstract][Full Text] [Related]  

  • 32. CD166 promotes the cancer stem-like properties of primary epithelial ovarian cancer cells.
    Kim DK; Ham MH; Lee SY; Shin MJ; Kim YE; Song P; Suh DS; Kim JH
    BMB Rep; 2020 Dec; 53(12):622-627. PubMed ID: 32843129
    [TBL] [Abstract][Full Text] [Related]  

  • 33. NFκB Promotes Ovarian Tumorigenesis via Classical Pathways That Support Proliferative Cancer Cells and Alternative Pathways That Support ALDH
    House CD; Jordan E; Hernandez L; Ozaki M; James JM; Kim M; Kruhlak MJ; Batchelor E; Elloumi F; Cam MC; Annunziata CM
    Cancer Res; 2017 Dec; 77(24):6927-6940. PubMed ID: 29074539
    [TBL] [Abstract][Full Text] [Related]  

  • 34. EZH2-Mediated Downregulation of the Tumor Suppressor DAB2IP Maintains Ovarian Cancer Stem Cells.
    Zong X; Wang W; Ozes A; Fang F; Sandusky GE; Nephew KP
    Cancer Res; 2020 Oct; 80(20):4371-4385. PubMed ID: 32816909
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lipid Desaturation Is a Metabolic Marker and Therapeutic Target of Ovarian Cancer Stem Cells.
    Li J; Condello S; Thomes-Pepin J; Ma X; Xia Y; Hurley TD; Matei D; Cheng JX
    Cell Stem Cell; 2017 Mar; 20(3):303-314.e5. PubMed ID: 28041894
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The Tumor-Associated Glycosyltransferase ST6Gal-I Regulates Stem Cell Transcription Factors and Confers a Cancer Stem Cell Phenotype.
    Schultz MJ; Holdbrooks AT; Chakraborty A; Grizzle WE; Landen CN; Buchsbaum DJ; Conner MG; Arend RC; Yoon KJ; Klug CA; Bullard DC; Kesterson RA; Oliver PG; O'Connor AK; Yoder BK; Bellis SL
    Cancer Res; 2016 Jul; 76(13):3978-88. PubMed ID: 27216178
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Molecular phenotyping of human ovarian cancer stem cells unravels the mechanisms for repair and chemoresistance.
    Alvero AB; Chen R; Fu HH; Montagna M; Schwartz PE; Rutherford T; Silasi DA; Steffensen KD; Waldstrom M; Visintin I; Mor G
    Cell Cycle; 2009 Jan; 8(1):158-66. PubMed ID: 19158483
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lysine-specific demethylase KDM3A regulates ovarian cancer stemness and chemoresistance.
    Ramadoss S; Sen S; Ramachandran I; Roy S; Chaudhuri G; Farias-Eisner R
    Oncogene; 2017 Mar; 36(11):1537-1545. PubMed ID: 27694900
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Characterization of aldehyde dehydrogenase 1 high ovarian cancer cells: Towards targeted stem cell therapy.
    Sharrow AC; Perkins B; Collector MI; Yu W; Simons BW; Jones RJ
    Gynecol Oncol; 2016 Aug; 142(2):341-8. PubMed ID: 27017984
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Matrix metalloproteinase-10 regulates stemness of ovarian cancer stem-like cells by activation of canonical Wnt signaling and can be a target of chemotherapy-resistant ovarian cancer.
    Mariya T; Hirohashi Y; Torigoe T; Tabuchi Y; Asano T; Saijo H; Kuroda T; Yasuda K; Mizuuchi M; Saito T; Sato N
    Oncotarget; 2016 May; 7(18):26806-22. PubMed ID: 27072580
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.